Our previous study also identified TLR7 as a candidate gene for stomach adenocarcinoma (STAD) via the WGCNA algorithm, and this could help predict the progression and prognosis of STAD and shed new light on its immunotherapy (Yuan et al., 2021b). This evidence concerns the gene TLR7 and gastric adenocarcinoma.